Pyrotinib in HER2-positive Early Breast Cancer

Clinical trial NCT06718335 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06718335
Sponsor: Nie Jianyun
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2024-12-30
Primary completion: 2027-12-30
Enrollment: 156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.